Bacterial Pneumonia

Patients with penicillin allergy labels experienced worse outcomes with bacterial pneumonia than patients who did not have these labels, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

BOSTON — Intubated patients with COVID-19 pneumonia who develop AKI in the hospital are at risk for developing chronic kidney disease, according to a presenter at the National Kidney Foundation Spring Clinical Meetings.

This week, the FDA grants approval on treatments for community-acquired bacterial pneumonia and cystic fibrosis; COVID-19 patients experience at least one persistent symptom; many patients self-identify the need for pulmonary rehab following COVID-19 hospitalization; and more.

Lefamulin demonstrated high early clinical response and was safe in patients with community-acquired bacterial pneumonia with advanced age and comorbidities, according to a post hoc, pooled analysis of the LEAP 1 and LEAP 2 trials.

The FDA has approved Fetroja for patients aged 18 years or older with hospital-acquired and ventilator-associated bacterial pneumonia, Shionogi announced.

The FDA approved Merck’s Recarbrio today, a three-drug combination antibiotic injection for the treatment of hospital-acquired bacterial pneumonia, or HABP, and ventilator-associated bacterial pneumonia, or VABP, in patients aged 18 years and older, according to a press release from the FDA.

The FDA today granted priority review to cefiderocol for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia.

The risk for invasive fungal disease is higher among smokers, according to data from a recent study, leading researchers to suggest that strategies to end smoking be implemented, particularly among those already at increased risk for invasive fungal disease.